Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Medical Genetics

Biological Mechanism and Getting the Right Diagnosis

At a Glance

Hereditary folate malabsorption can lower folate in both the blood and brain because disease-causing changes in SLC46A1 disrupt folate transport. A normal blood result does not rule it out; diagnosis combines blood tests, age-specific spinal-fluid 5-MTHF levels, and genetic testing.

Getting a diagnosis for Hereditary Folate Malabsorption (HFM) is often a complex puzzle. Because the condition is so rare, doctors must look past standard blood tests to understand what is happening inside the body and the central nervous system. Understanding the biological “why” behind the tests can help you advocate for the most accurate and timely diagnosis for your child.

The Biological “Double-Block”

HFM is caused by pathogenic variants in the SLC46A1 gene, which provides instructions for making the Proton-Coupled Folate Transporter (PCFT) [1]. In HFM, this transporter is impaired or missing, creating a “double-block” in the body:

  • Block 1 (The Gut): Folate from food or formula cannot be adequately absorbed into the bloodstream. This leads to systemic folate deficiency, causing blood issues like anemia [1][2].
  • Block 2 (The Central Nervous System): Even if some folate makes it into the blood, it struggles to transport into the cerebrospinal fluid (CSF). This leads to cerebral folate deficiency [1][3].

This differs from other conditions like FOLR1-related deficiency. In FOLR1, the gut usually works fine, so the child has enough folate in their blood, but a different transporter (the folate-receptor alpha) is broken at the blood-brain barrier [1][3]. HFM is unique because it affects both the body and the central nervous system simultaneously.

The Diagnostic Pitfall: “Normal” Blood Tests

One of the most dangerous hurdles in diagnosing HFM is that blood tests can sometimes be misleading. In children with HFM, the serum folate (the amount of folate in the blood) can sometimes appear to be within the normal range, especially if they have recently received supplements [2][4].

Because the blood and the cerebrospinal fluid are separate compartments, a child can have “normal” folate in their blood while their CSF remains deficient [4]. Serum and red-cell folate, complete blood count (CBC), homocysteine, and genetic results must all be interpreted together; a normal blood test should never be used on its own to dismiss the possibility of HFM [2].

Distinguishing HFM from Other Conditions

To evaluate HFM, doctors look at several specific markers to rule out “look-alike” conditions:

  • Megaloblastic Anemia: Doctors look for unusually large red blood cells on a CBC [4].
  • Homocysteine: Levels of this amino acid usually rise when folate is low [5][2].
  • Methylmalonic Acid (MMA): This test is useful for distinguishing isolated folate deficiency from many cases of Vitamin B12 (cobalamin) deficiency. While both conditions can cause similar types of anemia and high homocysteine, MMA typically rises in B12 deficiency [5][6]. However, MMA can also rise with renal impairment and certain metabolic disorders, so it must be interpreted alongside other clinical findings and genetic evaluation rather than treated as a definitive rule-out on its own.

The Definitive Tests

A diagnosis of HFM may be supported or confirmed using specialized steps:

  1. Lumbar Puncture (Spinal Tap): A lumbar puncture is an invasive but important procedure to measure the level of 5-MTHF (the active form of folate) in the cerebrospinal fluid, acting as a clinical proxy for central nervous system folate [2]. Because normal CSF folate levels naturally change as a child grows, these results must be compared against age-specific reference ranges rather than a single number [7][8].
  2. Genetic Testing: Confirmation typically requires identifying biallelic pathogenic or likely pathogenic variants in the SLC46A1 gene. While standard sequencing detects many cases, finding a “variant of uncertain significance” does not confirm the disease. If the phenotype remains strongly suggestive after a negative panel, a genetics professional can consider testing for deep intronic variants or large deletions [9][10].

Why Accurate Diagnosis Matters

Finding the right diagnosis quickly is essential. When the central nervous system lacks folate for too long, it can lead to permanent neurological damage or developmental regression [7][11]. However, once the diagnosis is confirmed, starting the correct prescription treatment (folinic acid) can stabilize the condition and, in many cases, lead to significant improvement in your child’s health and development [10][7].

Common questions in this guide

Can a child have HFM even when their blood folate is normal?
Yes. Blood folate can look normal, especially after supplementation, while folate remains low in the cerebrospinal fluid, the fluid surrounding the brain and spinal cord. A normal blood result alone should not rule out HFM.
What causes hereditary folate malabsorption?
HFM is usually caused by disease-causing changes in both copies of SLC46A1, the gene for the proton-coupled folate transporter. The resulting transporter problem can reduce folate absorption in the gut and limit folate entry into the brain, creating a two-part deficiency.
Which tests are used to diagnose HFM?
Doctors may combine serum and red-cell folate, a complete blood count, homocysteine, methylmalonic acid, cerebrospinal-fluid 5-MTHF, and genetic testing. Genetic confirmation usually requires pathogenic or likely pathogenic variants in both copies of SLC46A1, while cerebrospinal-fluid results need age-specific reference ranges.
Why is a spinal tap sometimes needed for suspected HFM?
A lumbar puncture allows doctors to measure 5-MTHF, the active form of folate, in cerebrospinal fluid. This can show whether folate is reaching the central nervous system when blood tests do not provide the full picture. Results should be compared with ranges for the child's age.
How is HFM different from FOLR1-related cerebral folate deficiency?
In HFM, SLC46A1-related transporter problems can impair folate absorption in the gut and movement into the brain. In FOLR1-related deficiency, the gut usually absorbs folate normally, but transport across the blood-brain barrier is impaired. HFM can therefore affect folate availability in both the blood and brain, while FOLR1-related deficiency may leave blood folate adequate.
What does a variant of uncertain significance mean for an HFM diagnosis?
A variant of uncertain significance is a genetic finding whose disease relevance is not established, so it does not confirm HFM by itself. If the child's clinical picture strongly suggests HFM after a negative or inconclusive panel, a genetics professional may consider testing for deep intronic variants or large deletions.
Can early treatment improve outcomes in HFM?
Once HFM is confirmed, prescription folinic acid can stabilize the condition and may lead to meaningful improvement in health and development. Prompt treatment is important because prolonged folate deficiency in the central nervous system can cause lasting neurological damage or developmental regression.

Get notified when new evidence is published on Hereditary folate malabsorption.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    The proton-coupled folate transporter (PCFT-SLC46A1) and the syndrome of systemic and cerebral folate deficiency of infancy: Hereditary folate malabsorption.

    Zhao R, Aluri S, Goldman ID

    Molecular aspects of medicine 2017; (53()):57-72 doi:10.1016/j.mam.2016.09.002.

    PMID: 27664775
  2. 2

    [Hereditary folate malabsorption due to an SLC46A1 mutation with cerebral folate deficiency and refractory epilepsy: first case reported in Argentina]

    Grosso CL, Peralta LV, Paviolo M, et al.

    Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) 2026; (83(3)):e50324 doi:10.31053/1853.0605.v83.n3.50324.

    PMID: 42809880
  3. 3

    Late diagnosis of cerebral folate deficiency: Fewer seizures with folinic acid in adult siblings.

    Ferreira P, Luco SM, Sawyer SL, et al.

    Neurology. Genetics 2016; (2(1)):e38 doi:10.1212/NXG.0000000000000038.

    PMID: 27066576
  4. 4

    [Two cases with generalized intracranial calcification due to hereditary folate malabsorption and literature review].

    Zhang Y, Wang Q, Li DX, et al.

    Zhonghua er ke za zhi = Chinese journal of pediatrics 2016; (54(12)):931-935 doi:10.3760/cma.j.issn.0578-1310.2016.12.012.

    PMID: 27938595
  5. 5

    Biomarkers and Algorithms for the Diagnosis of Vitamin B12 Deficiency.

    Hannibal L, Lysne V, Bjørke-Monsen AL, et al.

    Frontiers in molecular biosciences 2016; (3()):27 doi:10.3389/fmolb.2016.00027.

    PMID: 27446930
  6. 6

    [Maternal and neonatal vitamin B12 deficiency detected by expanded newborn screening].

    Papp F, Rácz G, Lénárt I, et al.

    Orvosi hetilap 2017; (158(48)):1909-1918 doi:10.1556/650.2017.30901.

    PMID: 29172662
  7. 7

    Role of Intramuscular Levofolinate Administration in the Treatment of Hereditary Folate Malabsorption: Report of Three Cases.

    Manea E, Gissen P, Pope S, et al.

    JIMD reports 2018; (39()):7-12 doi:10.1007/8904_2017_39.

    PMID: 28685492
  8. 8

    CSF 5-Methyltetrahydrofolate Serial Monitoring to Guide Treatment of Congenital Folate Malabsorption Due to Proton-Coupled Folate Transporter (PCFT) Deficiency.

    Torres A, Newton SA, Crompton B, et al.

    JIMD reports 2015; (24()):91-6 doi:10.1007/8904_2015_445.

    PMID: 26006721
  9. 9

    A deep intronic mutation of c.1166-285 T > G in SLC46A1 is shared by four unrelated Japanese patients with hereditary folate malabsorption (HFM).

    Tozawa Y, Abdrabou SSMA, Nogawa-Chida N, et al.

    Clinical immunology (Orlando, Fla.) 2019; (208()):108256 doi:10.1016/j.clim.2019.108256.

    PMID: 31494288
  10. 10

    Treatable Cause of Pancytopenia, Recurrent Infections and Refractory Epilepsy: Secondary to Hereditary Folate Malabsorption (HFM) Due to Novel Pathogenic Variant.

    Gowda VK, Battina M, Shivappa SK, Benakappa N

    Indian journal of pediatrics 2021; (88(6)):586-588 doi:10.1007/s12098-020-03548-w.

    PMID: 33146883
  11. 11

    Hereditary Folate Malabsorption Presenting With Pancytopenia in Two Siblings: A Case Report.

    N'joumi C, Ghanam A, Tkak H, et al.

    Cureus 2025; (17(8)):e89809 doi:10.7759/cureus.89809.

    PMID: 40937236

This page explains how hereditary folate malabsorption is evaluated in children for informational purposes only and does not constitute medical advice. A qualified clinician and genetics professional should interpret your child's blood, cerebrospinal fluid, and genetic results and guide testing or treatment.